Evidence map›Paper›PMID 37443320›Full record

ArticleNature communications2023

Exon-intron boundary inhibits m

Zhiyuan Luo, Qilian Ma, Shan Sun, Ningning Li, Hongfeng Wang, Zheng Ying, Shengdong Ke

Abstract read
In one paragraph

Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed.

  1. mNature reviews. Neuroscience · 2026
    Review
  2. Article
  3. Article
  4. High-stoichiometry mRNA (New York, N.Y.) · 2026
    Article
  5. Article
  6. Review
  7. Article
  8. Gene regulation through exon junction complex modularity.Nature structural & molecular biology · 2025
    Review
  9. Article
  10. FTO depletion does not alter mbioRxiv : the preprint server for biology · 2025
    Article
  11. Article
  12. Isoform-level profiling of mScience advances · 2025
    Article
  13. De novo assembly of RNA mCell reports · 2025
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Life science alliance · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Zhiyuan LuoThe Jackson Laboratory, Bar Harbor, ME, 04609, USA.
Qilian MaJiangsu Key Laboratory of Neuropsychiatric Diseases and College of Pharmaceutical Sciences, Soochow University, Suzhou, Jiangsu, 215123, China.
Shan SunJiangsu Key Laboratory of Neuropsychiatric Diseases and College of Pharmaceutical Sciences, Soochow University, Suzhou, Jiangsu, 215123, China.
Ningning LiJiangsu Key Laboratory of Neuropsychiatric Diseases and College of Pharmaceutical Sciences, Soochow University, Suzhou, Jiangsu, 215123, China.
Hongfeng WangJiangsu Key Laboratory of Neuropsychiatric Diseases and College of Pharmaceutical Sciences, Soochow University, Suzhou, Jiangsu, 215123, China.ORCID 0000-0003-4909-2260
Zheng YingJiangsu Key Laboratory of Neuropsychiatric Diseases and College of Pharmaceutical Sciences, Soochow University, Suzhou, Jiangsu, 215123, China. zheng.ying@suda.edu.cn.ORCID 0000-0002-1099-0509
Shengdong KeThe Jackson Laboratory, Bar Harbor, ME, 04609, USA. kelab018@gmail.com.ORCID 0000-0002-5994-8627

Funding

Shared Resource ManagementP30CA034196 · NCI · JACKSON LABORATORY · PI William Carl Skarnes · 1985 to 2026
$61.9M
The Molecular and Regulatory Mechanism of m6A mRNA ModificationR35GM133711 · NIGMS · JACKSON LABORATORY · PI KE, SHENGDONG · 2019 to 2021
$1.3M
NCI NIH HHS P30 CA034196NIGMS NIH HHS R35 GM133711
6 · The paper itself

Abstract

Regional bias of N

Indexed as

RNA PrecursorsRNA SplicingExonsHalf-LifeIntronsRNA, MessengerRNA, MessengerRNA Precursors

Identifiers

PMID37443320
PMCPMC10345190

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.